Stearns D J, Kurosawa S, Esmon C T
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City 73104.
J Biol Chem. 1989 Feb 25;264(6):3352-6.
Thrombomodulin is the endothelial cell cofactor for thrombin-catalyzed activation of protein C. Recently, we isolated a 10-kDa thrombin binding fragment, CB3, from the epidermal growth factor precursor homology domain (epidermal growth factor (EGF)-like regions) of thrombomodulin (Kurasawa, S., Stearns, D. J., Jackson, K.W., and Esmon, C.T. (1988) J. Biol. Chem. 263, 5993-5996). The CB3 fragment did not, however, support protein C activation. A 29-kDa fragment, called CB23, has now been isolated and corresponds to residues 310-486 in the EGF-like region of thrombomodulin. The CB23 fragment bound thrombin and accelerated thrombin-catalyzed protein C activation. With two separate preparations of CB23, the Km for protein C was 1.6 and 1.9 microM and the Kd for thrombin was 8.9 and 13.2 nM. The carboxyl terminus of CB23 and CB3 was identified by isolation and sequence analysis of a tryptic peptide from CB3. The sequence of this peptide corresponded to Asn457-Ser486, indicating that the carboxyl terminus of these fragments is 6 residues beyond the sixth EGF-like region of thrombomodulin. In addition, although CB3 cannot accelerate protein C activation, CB3 did inhibit the rate of thrombin-catalyzed fibrinopeptide release from fibrinogen. Thus, like native thrombomodulin, CB3 will alter thrombin's substrate specificity, but protein C activation requires additional information all of which can be provided by other regions of the EGF-like domain.
血栓调节蛋白是凝血酶催化蛋白C活化的内皮细胞辅因子。最近,我们从血栓调节蛋白的表皮生长因子前体同源结构域(表皮生长因子(EGF)样区域)中分离出一个10 kDa的凝血酶结合片段CB3(仓泽,S.,斯特恩斯,D.J.,杰克逊,K.W.,和埃斯蒙,C.T.(1988年)《生物化学杂志》263,5993 - 5996)。然而,CB3片段不支持蛋白C活化。现在已经分离出一个29 kDa的片段,称为CB23,它对应于血栓调节蛋白EGF样区域中的310 - 486位氨基酸残基。CB23片段结合凝血酶并加速凝血酶催化的蛋白C活化。对于两种不同制备的CB23,蛋白C的米氏常数(Km)分别为1.6和1.9 μM,凝血酶的解离常数(Kd)分别为8.9和13.2 nM。通过从CB3中分离和测序胰蛋白酶肽段鉴定了CB23和CB3的羧基末端。该肽段的序列对应于Asn457 - Ser486,表明这些片段的羧基末端在血栓调节蛋白第六个EGF样区域之后6个氨基酸残基处。此外,虽然CB3不能加速蛋白C活化,但CB3确实抑制了凝血酶催化的纤维蛋白原纤维蛋白肽释放速率。因此,与天然血栓调节蛋白一样,CB3会改变凝血酶的底物特异性,但蛋白C活化需要其他信息,所有这些信息都可以由EGF样结构域的其他区域提供。